Literature DB >> 29891719

Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis.

Palak Amin1, Marcus Florez1, Ayaz Najafov1, Heling Pan2, Jiefei Geng1, Dimitry Ofengeim1, Slawomir A Dziedzic1, Huibing Wang1, Vica Jean Barrett1, Yasushi Ito1, Matthew J LaVoie3, Junying Yuan4,2.   

Abstract

Stimulation of cells with TNFα can promote distinct cell death pathways, including RIPK1-independent apoptosis, necroptosis, and RIPK1-dependent apoptosis (RDA)-the latter of which we still know little about. Here we show that RDA involves the rapid formation of a distinct detergent-insoluble, highly ubiquitinated, and activated RIPK1 pool, termed "iuRIPK1." iuRIPK1 forms after RIPK1 activation in TNF-receptor-associated complex I, and before cytosolic complex II formation and caspase activation. To identify regulators of iuRIPK1 formation and RIPK1 activation in RDA, we conducted a targeted siRNA screen of 1,288 genes. We found that NEK1, whose loss-of-function mutations have been identified in 3% of ALS patients, binds to activated RIPK1 and restricts RDA by negatively regulating formation of iuRIPK1, while LRRK2, a kinase implicated in Parkinson's disease, promotes RIPK1 activation and association with complex I in RDA. Further, the E3 ligases APC11 and c-Cbl promote RDA, and c-Cbl is recruited to complex I in RDA, where it promotes prodeath K63-ubiquitination of RIPK1 to lead to iuRIPK1 formation. Finally, we show that two different modes of necroptosis induction by TNFα exist which are differentially regulated by iuRIPK1 formation. Overall, this work reveals a distinct mechanism of RIPK1 activation that mediates the signaling mechanism of RDA as well as a type of necroptosis.

Entities:  

Keywords:  RIPK1; TNF; apoptosis; necroptosis; ubiquitination

Mesh:

Substances:

Year:  2018        PMID: 29891719      PMCID: PMC6042106          DOI: 10.1073/pnas.1806973115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Cdh1-APC controls axonal growth and patterning in the mammalian brain.

Authors:  Yoshiyuki Konishi; Judith Stegmüller; Takahiko Matsuda; Shirin Bonni; Azad Bonni
Journal:  Science       Date:  2004-01-08       Impact factor: 47.728

2.  CIN85 associates with TNF receptor 1 via Src and modulates TNF-alpha-induced apoptosis.

Authors:  Tadashi Narita; Tadahiro Nishimura; Kazuyuki Yoshizaki; Tadayoshi Taniyama
Journal:  Exp Cell Res       Date:  2004-12-01       Impact factor: 3.905

3.  NEK1 mutations in familial amyotrophic lateral sclerosis.

Authors:  David Brenner; Kathrin Müller; Thomas Wieland; Patrick Weydt; Sarah Böhm; Dorothée Lulé; Annemarie Hübers; Christoph Neuwirth; Markus Weber; Guntram Borck; Magnus Wahlqvist; Karin M Danzer; Alexander E Volk; Thomas Meitinger; Tim M Strom; Markus Otto; Jan Kassubek; Albert C Ludolph; Peter M Andersen; Jochen H Weishaupt
Journal:  Brain       Date:  2016-03-05       Impact factor: 13.501

4.  TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.

Authors:  Betty Lamothe; YunJu Lai; Min Xie; Michael D Schneider; Bryant G Darnay
Journal:  Mol Cell Biol       Date:  2012-11-19       Impact factor: 4.272

5.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

6.  RIPK1 mediates a disease-associated microglial response in Alzheimer's disease.

Authors:  Dimitry Ofengeim; Sonia Mazzitelli; Yasushi Ito; Judy Park DeWitt; Lauren Mifflin; Chengyu Zou; Sudeshna Das; Xian Adiconis; Hongbo Chen; Hong Zhu; Michelle A Kelliher; Joshua Z Levin; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-13       Impact factor: 11.205

7.  RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.

Authors:  Yasushi Ito; Dimitry Ofengeim; Ayaz Najafov; Sudeshna Das; Shahram Saberi; Ying Li; Junichi Hitomi; Hong Zhu; Hongbo Chen; Lior Mayo; Jiefei Geng; Palak Amin; Judy Park DeWitt; Adnan Kasim Mookhtiar; Marcus Florez; Amanda Tomie Ouchida; Jian-bing Fan; Manolis Pasparakis; Michelle A Kelliher; John Ravits; Junying Yuan
Journal:  Science       Date:  2016-08-05       Impact factor: 47.728

8.  Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.

Authors:  Scott B Berger; Viera Kasparcova; Sandy Hoffman; Barb Swift; Lauren Dare; Michelle Schaeffer; Carol Capriotti; Michael Cook; Joshua Finger; Angela Hughes-Earle; Philip A Harris; William J Kaiser; Edward S Mocarski; John Bertin; Peter J Gough
Journal:  J Immunol       Date:  2014-05-12       Impact factor: 5.422

9.  Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.

Authors:  Jiefei Geng; Yasushi Ito; Linyu Shi; Palak Amin; Jiachen Chu; Amanda Tomie Ouchida; Adnan Kasim Mookhtiar; Heng Zhao; Daichao Xu; Bing Shan; Ayaz Najafov; Guangping Gao; Shizuo Akira; Junying Yuan
Journal:  Nat Commun       Date:  2017-08-25       Impact factor: 14.919

10.  Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2.

Authors:  Alessandro Annibaldi; Sidonie Wicky John; Tom Vanden Berghe; Kirby N Swatek; Jianbin Ruan; Gianmaria Liccardi; Katiuscia Bianchi; Paul R Elliott; Sze Men Choi; Samya Van Coillie; John Bertin; Hao Wu; David Komander; Peter Vandenabeele; John Silke; Pascal Meier
Journal:  Mol Cell       Date:  2018-02-15       Impact factor: 17.970

View more
  47 in total

1.  Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.

Authors:  Alyssa D Smith; Chunwan Lu; Daniela Payne; Amy V Paschall; John D Klement; Priscilla S Redd; Mohammed L Ibrahim; Dafeng Yang; Qimei Han; Zhuoqi Liu; Huidong Shi; Thomas J Hartney; Asha Nayak-Kapoor; Kebin Liu
Journal:  Cancer Res       Date:  2020-06-17       Impact factor: 12.701

2.  Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke.

Authors:  Masanori Gomi Naito; Daichao Xu; Palak Amin; Jinwoo Lee; Huibing Wang; Wanjin Li; Michelle Kelliher; Manolis Pasparakis; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

Review 3.  Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases.

Authors:  Junying Yuan; Palak Amin; Dimitry Ofengeim
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

Review 4.  Programming inflammatory cell death for therapy.

Authors:  Shelbi Christgen; Rebecca E Tweedell; Thirumala-Devi Kanneganti
Journal:  Pharmacol Ther       Date:  2021-10-04       Impact factor: 12.310

5.  The death-inducing activity of RIPK1 is regulated by the pH environment.

Authors:  Kenta Moriwaki; Sakthi Balaji; Francis Ka-Ming Chan
Journal:  Sci Signal       Date:  2020-05-12       Impact factor: 8.192

Review 6.  The regulation of necroptosis by post-translational modifications.

Authors:  Yanxiang Meng; Jarrod J Sandow; Peter E Czabotar; James M Murphy
Journal:  Cell Death Differ       Date:  2021-01-18       Impact factor: 15.828

7.  RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis.

Authors:  Zhuming Yin; Wenlin Chen; Jian Yin; Jingyan Sun; Qianrong Xie; Min Wu; Fanxin Zeng; Huiwen Ren
Journal:  NPJ Breast Cancer       Date:  2021-05-12

8.  New Succinimides with Potent Anticancer Activity: Synthesis, Activation of Stress Signaling Pathways and Characterization of Apoptosis in Leukemia and Cervical Cancer Cells.

Authors:  Marcin Cieślak; Mariola Napiórkowska; Julia Kaźmierczak-Barańska; Karolina Królewska-Golińska; Anna Hawrył; Iwona Wybrańska; Barbara Nawrot
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 9.  Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators.

Authors:  Jinho Seo; Young Woo Nam; Seongmi Kim; Doo-Byoung Oh; Jaewhan Song
Journal:  Exp Mol Med       Date:  2021-06-01       Impact factor: 8.718

Review 10.  RIPK protein kinase family: Atypical lives of typical kinases.

Authors:  Gregory D Cuny; Alexei Degterev
Journal:  Semin Cell Dev Biol       Date:  2020-07-27       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.